Pharvaris Analyst Price Targets - Benzinga

Pharvaris NV

PHVSNASDAQ

Trade with Public

Trade with Public

$35.21

2.688.24%

Últ. Act.: Nov 6, 1:33 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Pharvaris Analyst Price Targets - Benzinga

Pharvaris Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pharvaris (PHVS).

Price Target Range — 12 Quarters

Analyst Consensus — 15 Analysts

3S.Buy

12Buy

Consensus RatingOutperform# Analysts15Avg. Consensus PT$51Upside to Avg. PT+45.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 23, 2026	B of A Securities	Tazeen Ahmad	Upgrade	Neutral→Buy	$44
Sep 10, 2026	Guggenheim	Debjit Chattopadhyay	PT Raise	Buy	$40→$44
Sep 9, 2026	Morgan Stanley	Maxwell Skor	PT Raise	Overweight	$46→$62
Sep 9, 2026	Leerink Partners	Joseph Schwartz	PT Raise	Outperform	$50→$65
Sep 9, 2026	Wells Fargo	Yanan Zhu	PT Raise	Overweight	$55→$65
Sep 9, 2026	RBC Capital	Nevin Varghese	PT Raise	Outperform	$52→$62
Sep 9, 2026	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$75→$79
Sep 9, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$42→$50
Sep 8, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$60
Sep 8, 2026	Wedbush	Laura Chico	Maintained	Outperform	$42
Aug 13, 2026	RBC Capital	Brian Abrahams	PT Raise	Outperform	$51→$52
Aug 13, 2026	Guggenheim	Debjit Chattopadhyay	PT Raise	Buy	$39→$40
Aug 13, 2026	Citizens	Jonathan Wolleben	PT Raise	Market Outperform	$74→$75
Jul 15, 2026	Wells Fargo	Yanan Zhu	Initiate	Overweight	$55
Jun 25, 2026	Morgan Stanley	Maxwell Skor	PT Raise	Overweight	$41→$46
May 13, 2026	Citizens	Jonathan Wolleben	PT Cut	Market Outperform	$75→$74
Apr 9, 2026	Wolfe Research	Andy Chen	Initiate	Outperform	$42
Apr 7, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$41→$42
Apr 6, 2026	RBC Capital	Brian Abrahams	PT Cut	Outperform	$52→$51
Mar 9, 2026	RBC Capital	Brian Abrahams	Initiate	Outperform	$52

Analyst Ratings News

This Monolithic Power Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

Analysts upgraded Incyte, Intel, Rivian and Monolithic Power, raising ratings and targets; MPWR’s target increased to $1,700.

Avi Kapoor

This Hilton Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Analysts upgraded VF Corp, Hilton, Ares Capital, eBay and Wintrust Financial, raising targets for VF, Hilton, eBay and Wintrust.

Avi Kapoor

This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Analysts upgraded SAFE, CNOB, LMT and more.

Avi Kapoor

Two Pills, One Target: Analyst Bets on Pharvaris as Clinical Risks Fade

Bank of America upgrades Pharvaris to Buy with a new price target, citing reduced clinical risk for deucrictibant in hereditary angioedema despite market competition.

Vandana Singh

This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Raymond James

Avi Kapoor

PRO
B of A Securities Upgrades Pharvaris to Buy, Maintains Price Target to $44

B of A Securities analyst Tazeen Ahmad upgrades Pharvaris (NASDAQ:PHVS) from Neutral to Buy and maintains the price target from $44 to $44.

Benzinga Newsdesk